Ulcerated hemosiderinic dyschromia and iron deposits within lower limbs treated with a topical application of biological chelator

Abstract

The ulcerative haemosiderinic dyschromia of chronic venous insufficiency is difficult to heal and presents a high accumulation of iron. Lactoferrin, a potent natural iron chelator, could help to scar this ulcerative haemosiderinic dyschromia. The objective of this study was to determine whether the topical application of a liposomal gel with Lactoferrin favors scarring/degradation of the brown colored spot typical of ulcerative haemosiderinic dyschromia. Nine patients with severe chronic venous insufficiency and ulcerative haemosiderinic dyschromia (CEAP-C6), with a natural evolution of over 12 months, were included in the study. Hemo chromatosis gene mutations were investigated. The levels of serum ferritin, transferrin saturation and blood cell counts were analyzed. The presence of hemosiderin was investigated through periulcerous and ulcer fundus biopsies carried out at baseline and 30 days after treatment with Lactoferrin. The severity of the injuries (CEAP classification) was evaluated at the beginning of and throughout the whole 3-month treatment period. No patient had received compression treatment during the three months previous to this therapy. Significant improvement in these injuries, with a reduction in the dimensions of the brown spot (9 of 9) at Day 90, and complete scarring with a closure time ranging from 15 to 180 days (7 of 9) were observed. The use of topical lactoferrin is a non-invasive therapeutic tool that favors clearance of hemosiderinic dyschromia and scarring of the ulcer. The success of this study was not influenced either by the hemochromatosis genetics or the iron metabolism profile observed.

Myocardial Iron Overload in an Experimental Model of Sudden Unexpected Death in Epilepsy

“…CMR-derived T2* enables accurate diagnosis and quantification of myocardial and hepatic iron deposition, and hence the tailoring and monitoring of iron chelation therapy, thereby improving survival as in cases of thalassemia major ( 45 , 53 ). Similarly, the topical application of the biological chelator lactoferrin to ulcerated legs of patients with ulcerative hemosiderinic dyschromia of chronic venous insufficiency, significantly reduced hemosiderin deposits, thus favoring the clearance of the iron deposition in the ulcerated legs as well as a complete ulcer scarring ( 54 ). Consistent with the possible use of CMR-derived T2* determining the iron heart, magnetic resonance imaging (MRI) with T1 mapping can distinguish fibrosis, edema, lipid accumulation, and iron and amyloid deposition ( 55 ).…”

Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities

“…Interestingly, the topical application of a liposomal gel with lactoferrin, the most potent natural iron chelator, to ulcerative lesions on the lower limbs of patients presenting with chronic venous insufficiency, proved to be effective for the complete scarring of these refractory ulcerative haemosiderinic dyschromic lesions, with complete restoration of muscle, vessel, nerve and skin tissues in 7 of 9 cases [54].…”

Can We Treat Neuroinflammation in Alzheimer’s Disease?

“…For example, lactoferrin (a multifunctional iron-binding glycoprotein) administration increases insulin sensitivity in adipose tissue explants from obese subjects [ 47 , 48 ]. Indeed, Lactoferrin antioxidant function is highly dependent on its iron binding capacity [ 49 ]. In metabolic syndromes, iron accumulation is considered an important factor underlying insulin resistance and oxidative stress; accordingly, iron-chelators have a positive effect ameliorating the physiopathology of obesity.…”